These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33441861)

  • 1. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA).
    Mancini F; Gasperini G; Rossi O; Aruta MG; Raso MM; Alfini R; Biagini M; Necchi F; Micoli F
    Sci Rep; 2021 Jan; 11(1):906. PubMed ID: 33441861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against
    Mancini F; Alfini R; Caradonna V; Monaci V; Carducci M; Gasperini G; Piccioli D; Biagini M; Giannelli C; Rossi O; Pizza M; Micoli F
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB.
    Gerke C; Colucci AM; Giannelli C; Sanzone S; Vitali CG; Sollai L; Rossi O; Martin LB; Auerbach J; Di Cioccio V; Saul A
    PLoS One; 2015; 10(8):e0134478. PubMed ID: 26248044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies Elicited by the
    Micoli F; Rossi O; Conti V; Launay O; Sciré AS; Aruta MG; Nakakana UN; Marchetti E; Rappuoli R; Saul A; Martin LB; Necchi F; Podda A
    Front Immunol; 2021; 12():671325. PubMed ID: 34017343
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations.
    Maggiore L; Yu L; Omasits U; Rossi O; Dougan G; Thomson NR; Saul A; Choudhary JS; Gerke C
    Int J Med Microbiol; 2016 Feb; 306(2):99-108. PubMed ID: 26746581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach.
    Necchi F; Carducci M; Pisoni I; Rossi O; Saul A; Rondini S
    J Immunol Methods; 2019 Aug; 471():11-17. PubMed ID: 31039338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-mediated serum bactericidal activity of antibodies elicited by the
    Kapulu MC; Nakakana U; Sciré AS; Sarakinou E; Conti V; Rossi O; Acquaviva A; Necchi F; Obiero CW; Martin LB; Bejon P; Njuguna P; Micoli F; Podda A
    Front Immunol; 2022; 13():971866. PubMed ID: 36203568
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of O-Antigen Chain Length Regulation on the Immunogenicity of
    Gasperini G; Raso MM; Arato V; Aruta MG; Cescutti P; Necchi F; Micoli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.
    Launay O; Lewis DJM; Anemona A; Loulergue P; Leahy J; Sciré AS; Maugard A; Marchetti E; Zancan S; Huo Z; Rondini S; Marhaba R; Finco O; Martin LB; Auerbach J; Cohen D; Saul A; Gerke C; Podda A
    EBioMedicine; 2017 Aug; 22():164-172. PubMed ID: 28735965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes.
    Citiulo F; Necchi F; Mancini F; Rossi O; Aruta MG; Gasperini G; Alfini R; Rondini S; Micoli F; Rappuoli R; Saul A; Martin LB
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009826. PubMed ID: 34644291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Booster Vaccination With GVGH
    Launay O; Ndiaye AGW; Conti V; Loulergue P; Sciré AS; Landre AM; Ferruzzi P; Nedjaai N; Schütte LD; Auerbach J; Marchetti E; Saul A; Martin LB; Podda A
    Front Immunol; 2019; 10():335. PubMed ID: 30906291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal
    Schager AE; Dominguez-Medina CC; Necchi F; Micoli F; Goh YS; Goodall M; Flores-Langarica A; Bobat S; Cook CNL; Arcuri M; Marini A; King LDW; Morris FC; Anderson G; Toellner KM; Henderson IR; López-Macías C; MacLennan CA; Cunningham AF
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal
    Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    De Benedetto G; Alfini R; Cescutti P; Caboni M; Lanzilao L; Necchi F; Saul A; MacLennan CA; Rondini S; Micoli F
    Vaccine; 2017 Jan; 35(3):419-426. PubMed ID: 27998639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants.
    Rossi O; Pesce I; Giannelli C; Aprea S; Caboni M; Citiulo F; Valentini S; Ferlenghi I; MacLennan CA; D'Oro U; Saul A; Gerke C
    J Biol Chem; 2014 Sep; 289(36):24922-35. PubMed ID: 25023285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against
    Obiero CW; Ndiaye AGW; Sciré AS; Kaunyangi BM; Marchetti E; Gone AM; Schütte LD; Riccucci D; Auerbach J; Saul A; Martin LB; Bejon P; Njuguna P; Podda A
    Front Immunol; 2017; 8():1884. PubMed ID: 29375556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting
    Tondi S; Clemente B; Esposito C; Sammicheli C; Tavarini S; Martin LB; Rossi O; Micoli F; Bartolini E; Brazzoli M; Ulivieri C; Blohmke CJ; Schiavetti F
    Front Cell Infect Microbiol; 2022; 12():767153. PubMed ID: 35186786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
    Black RE; Levine MM; Clements ML; Losonsky G; Herrington D; Berman S; Formal SB
    J Infect Dis; 1987 Jun; 155(6):1260-5. PubMed ID: 2437220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Signature of Monocytes Shaped by the
    Tondi S; Siena E; Essaghir A; Bozzetti B; Bechtold V; Scaillet A; Clemente B; Marrocco M; Sammicheli C; Tavarini S; Micoli F; Oldrini D; Pezzicoli A; Di Fede M; Brazzoli M; Ulivieri C; Schiavetti F
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens.
    Gasperini G; Raso MM; Schiavo F; Aruta MG; Ravenscroft N; Bellich B; Cescutti P; Necchi F; Rappuoli R; Micoli F
    NPJ Vaccines; 2022 Jun; 7(1):69. PubMed ID: 35773292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.